| Bioactivity | GSK466317A is a PKA inhibitor, with an IC50 of 12.59 μM. GSK466317A also inhibits GRK1, GRK2, and GRK5, with IC50s of 1000, 31.62, and 39.81 μM, respectively[1]. |
| Name | GSK466317A |
| CAS | 864082-48-4 |
| Formula | C21H16ClF3N4O2 |
| Molar Mass | 448.83 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Homan KT, et, al. Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors. ACS Chem Biol. 2015 Jan 16;10(1):310-9. |
GSK466317A
CAS: 864082-48-4 F: C21H16ClF3N4O2 W: 448.83
GSK466317A is a PKA inhibitor, with an IC50 of 12.59 μM. GSK466317A also inhibits GRK1, GRK2, and GRK5, with IC50s of 1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.